Citations 1
754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)
Chumsri, Saranya , Migdady, Yazan , Chaudhary, Lubna N. , Kim, Chul , Fitzsimmons, Sarah, Ganguly, Bishwa J, Hiraragi, Hajime, Jensen, H.R., Kim, Yeonhee , Lessig, Mary, Gillenwater, Heidi H., Spigel, David R. , Hamilton, Erika , Bashir, Babar , Gergis, Usama , Murthy, Hemant S. , Specht, Jennifer M. , Garber, Haven R. , Mamdani, Hirva Mansurali , Jensen, Helle
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A850-A850
